[1]

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, et al. 2024. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149:e347−e913

doi: 10.1161/CIR.0000000000001209
[2]

Institute for Health Metrics and Evaluation (IHME). 2022. Global Burden of Disease (GBD). Featured GBD 2021 publication. Seattle, WA, USA: IHME. www.healthdata.org/research-analysis/gbd (Access on 5 August 2024

[3]

Wei LK, Sutherland H, Au A, Camilleri E, Haupt LM, et al. 2016. Methylenetetrahydrofolate reductase CpG islands: epigenotyping. Journal of Clinical Laboratory Analysis 30(4):335−44

doi: 10.1002/jcla.21860
[4]

Lin RT, Hsi E, Lin HF, Liao YC, Wang YS, et al. 2014. LINE-1 methylation is associated with an increased risk of ischemic stroke in men. Current Neurovascular Research 11(1):4−9

doi: 10.2174/1567202610666131202145530
[5]

Qin X, Li J, Wu T, Wu Y, Tang X, et al. 2019. Overall and sex-specific associations between methylation of the ABCG1 and APOE genes and ischemic stroke or other atherosclerosis-related traits in a sibling study of Chinese population. Clinical Epigenetics 11:189

doi: 10.1186/s13148-019-0784-0
[6]

Keat Wei L, Sutherland H, Au A, Camilleri E, Haupt LM, et al. 2015. A potential epigenetic marker mediating serum folate and vitamin B12 levels contributes to the risk of ischemic stroke. BioMed Research International 2015(1):167976

doi: 10.1155/2015/167976
[7]

Zhang H, Mo X, Wang A, Peng H, Guo D, et al. 2022. Association of DNA methylation in blood pressure-related genes with ischemic stroke risk and prognosis. Frontiers in Cardiovascular Medicine 9:796245

doi: 10.3389/fcvm.2022.796245
[8]

Aria M, Cuccurullo C. 2017. bibliometrix: an R-tool for comprehensive science mapping analysis. Journal of Informetrics 11(4):959−75

doi: 10.1016/j.joi.2017.08.007
[9]

Arruda H, Silva ER, Lessa M, Proença D Jr, Bartholo R. 2022. VOSviewer and bibliometrix. Journal of the Medical Library Association 110(3):392

doi: 10.5195/jmla.2022.1434
[10]

Chen C. 2018. Visualizing and exploring scientific literature with Citespace: An introduction. CHIIR '18: Proceedings of the 2018 Conference on Human Information Interaction & Retrieval, New Brunswick, NJ, USA, March 11−15, 2018. New York, USA: Association for Computing Machinery. pp. 369−70. doi: 10.1145/3176349.3176897

[11]

Patnala R, Arumugam TV, Gupta N, Dheen ST. 2017. HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke. Molecular Neurobiology 54:6391−411

doi: 10.1007/s12035-016-0149-z
[12]

Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, et al. 2010. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21(6):819−28

doi: 10.1097/EDE.0b013e3181f20457
[13]

Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NLM, et al. 2012. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 43(12):3161−67

doi: 10.1161/STROKEAHA.112.665760
[14]

Gallego-Fabrega C, Carrera C, Reny JL, Fontana P, Slowik A, et al. 2016. TRAF3 epigenetic regulation is associated with vascular recurrence in patients with ischemic stroke. Stroke 47(5):1180−86

doi: 10.1161/STROKEAHA.115.012237
[15]

Krupinski J, Carrera C, Muiño E, Torres N, Al-Baradie R, et al. 2018. DNA methylation in stroke. Update of latest advances. Computational and Structural Biotechnology Journal 16:1−5

doi: 10.1016/j.csbj.2017.12.001
[16]

Soriano-Tárraga C, Jiménez-Conde J, Giralt-Steinhauer E, Mola M, Ois A, et al. 2014. Global DNA methylation of ischemic stroke subtypes. PLoS One 9(4):e96543

doi: 10.1371/journal.pone.0096543
[17]

Soriano-Tárraga C, Mola-Caminal M, Giralt-Steinhauer E, Ois A, Rodríguez-Campello A, et al. 2017. Biological age is better than chronological as predictor of 3-month outcome in ischemic stroke. Neurology 89(8):830−36

doi: 10.1212/WNL.0000000000004261
[18]

Wang W, Jiang B, Sun H, Ru X, Sun D, et al. 2017. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults. Circulation 135(8):759−71

doi: 10.1161/CIRCULATIONAHA.116.025250
[19]

Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, et al. 2014. DNA methylation map of human atherosclerosis. Circulation: Cardiovascular Genetics 7(5):692−700

doi: 10.1161/CIRCGENETICS.113.000441
[20]

Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35−41

doi: 10.1161/01.str.24.1.35
[21]

Pidsley R, Wong CCY, Volta M, Lunnon K, Mill J, et al. 2013. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 14:293

doi: 10.1186/1471-2164-14-293
[22]

Portela A, Esteller M. 2010. Epigenetic modifications and human disease. Nature Biotechnology 28(10):1057−68

doi: 10.1038/nbt.1685
[23]

International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, et al. 2012. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics 44(3):328−33

doi: 10.1038/ng.1081
[24]

Markus HS, Mäkelä KM, Bevan S, Raitoharju E, Oksala N, et al. 2013. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 44(5):1220−5

doi: 10.1161/STROKEAHA.111.000217
[25]

Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, et al. 2012. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. The Lancet Neurology 11(11):951−62

doi: 10.1016/S1474-4422(12)70234-X
[26]

Narne P, Pandey V, Phanithi PB. 2017. Interplay between mitochondrial metabolism and oxidative stress in ischemic stroke: an epigenetic connection. Molecular and Cellular Neuroscience 82:176−94

doi: 10.1016/j.mcn.2017.05.008
[27]

Shroff N, Ander BP, Zhan X, Stamova B, Liu D, et al. 2019. HDAC9 polymorphism alters blood gene expression in patients with large vessel atherosclerotic stroke. Translational Stroke Research 10:19−25

doi: 10.1007/s12975-018-0619-x
[28]

Wang Z, Su Y, Zhang L, Lan T, Li L, et al. 2022. GSK-126 protects CA1 neurons from H3K27me3-mediated apoptosis in cerebral ischemia. Molecular Neurobiology 59(4):2552−62

doi: 10.1007/s12035-021-02677-3
[29]

Thushara Vijayakumar N, Sangwan A, Sharma B, Majid A, Gk R. 2016. Cerebral ischemic preconditioning: the road so far…. Molecular Neurobiology 53(4):2579−93

doi: 10.1007/s12035-015-9278-z
[30]

Cai Y, Zhang Y, Ke X, Guo Y, Yao C, et al. 2019. Transcriptome sequencing unravels potential biomarkers at different stages of cerebral ischemic stroke. Frontiers in Genetics 10:814

doi: 10.3389/fgene.2019.00814
[31]

Zhang FF, Zhang L, Zhao L, Lu Y, Dong X, et al. 2023. The circular RNA Rap1b promotes Hoxa5 transcription by recruiting Kat7 and leading to increased Fam3a expression, which inhibits neuronal apoptosis in acute ischemic stroke. Neural Regeneration Research 18(10):2237−45

doi: 10.4103/1673-5374.369115
[32]

Shen X, Dong N, Xu Y, Han L, Yang R, et al. 2022. Analyzing Corin–BNP–NEP protein pathway revealing differential mechanisms in AF-related ischemic stroke and no AF-related ischemic stroke. Frontiers in Aging Neuroscience 14:863489

doi: 10.3389/fnagi.2022.863489
[33]

Zhang X, Wang Y, Dong B, Jiang Y, Liu D, et al. 2022. Expression pattern and clinical value of key RNA methylation modification regulators in ischemic stroke. Frontiers in Genetics 13:1009145

doi: 10.3389/fgene.2022.1009145
[34]

Bie X, Zhao H, Zhang Z, Wang X, Luan Y, et al. 2021. Epigenetic regulation mechanism of DNA methylation and miRNAs on the expression of the ALOX5AP gene in patients with ischemic stroke. Experimental and Therapeutic Medicine 22(6):1484

doi: 10.3892/etm.2021.10919
[35]

Liu Y, Shang G, Zhang X, Liu F, Zhang C, et al. 2022. CAMTA1 gene affects the ischemia-reperfusion injury by regulating CCND1. Frontiers in Cellular Neuroscience 16:868291

doi: 10.3389/fncel.2022.868291
[36]

Qin X, Karlsson IK, Wang Y, Li X, Pedersen N, et al. 2021. The epigenetic etiology of cardiovascular disease in a longitudinal Swedish twin study. Clinical Epigenetics 13(1):129

doi: 10.1186/s13148-021-01113-6
[37]

Gallego-Fabrega C, Carrera C, Reny JL, Fontana P, Slowik A, et al. 2016. PPM1A methylation is associated with vascular recurrence in aspirin-treated patients. Stroke 47(7):1926−29

doi: 10.1161/STROKEAHA.116.013340
[38]

Shen Y, Peng C, Bai Q, Ding Y, Yi X, et al. 2019. Epigenome-wide association study indicates hypomethylation of MTRNR2L8 in large-artery atherosclerosis stroke. Stroke 50(6):1330−38

doi: 10.1161/STROKEAHA.118.023436
[39]

Haitjema S, Meddens CA, Van Der Laan SW, Kofink D, Harakalova M, et al. 2017. Additional candidate genes for human atherosclerotic disease identified through annotation based on chromatin organization. Circulation: Cardiovascular Genetics 10(2):e001664

doi: 10.1161/CIRCGENETICS.116.001664
[40]

Dennis J, Medina-Rivera A, Truong V, Antounians L, Zwingerman N, et al. 2017. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels. Genetic Epidemiology 41(5):455−66

doi: 10.1002/gepi.22049
[41]

Soriano-Tárraga C, Giralt-Steinhauer E, Mola-Caminal M, Vivanco-Hidalgo RM, Ois A, et al. 2016. Ischemic stroke patients are biologically older than their chronological age. Aging 8(11):2655

doi: 10.18632/aging.101028
[42]

Jiménez-Balado J, Giralt-Steinhauer E, Fernández-Pérez I, Rey L, Cuadrado-Godia E, et al. 2022. Epigenetic clock explains white matter hyperintensity burden irrespective of chronological age. Biology 12(1):33

doi: 10.3390/biology12010033
[43]

Soriano-Tárraga C, Lazcano U, Jiménez-Conde J, Ois A, Cuadrado-Godia E, et al. 2021. Biological age is a novel biomarker to predict stroke recurrence. Journal of Neurology 268:285−92

doi: 10.1007/s00415-020-10148-3
[44]

Wei Y, Sun Z, Wang Y, Xie Z, Xu S, et al. 2019. Methylation in the TP53 promoter is associated with ischemic stroke. Molecular Medicine Reports 20(2):1404−10

doi: 10.3892/mmr.2019.10348
[45]

Kim JY, Choi BG, Jelinek J, Kim DH, Lee SH, et al. 2020. Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis. Clinical Epigenetics 12:66

doi: 10.1186/s13148-020-00846-0
[46]

Davis Armstrong NM, Chen WM, Brewer MS, Williams SR, Sale MM, et al. 2018. Epigenome-wide analyses identify two novel associations with recurrent stroke in the vitamin intervention for stroke prevention clinical trial. Frontiers in Genetics 9:358

doi: 10.3389/fgene.2018.00358
[47]

Turunen MP, Aavik E, Ylä-Herttuala S. 2009. Epigenetics and atherosclerosis. Biochimica et Biophysica Acta 1790(9):886−91

doi: 10.1016/j.bbagen.2009.02.008
[48]

Wang Z, Song WQ, Wang L. 2017. Application of noninvasive brain stimulation for post-stroke dysphagia rehabilitation. The Kaohsiung Journal of Medical Sciences 33(2):55−61

doi: 10.1016/j.kjms.2016.11.007
[49]

Cullell N, Soriano-Tárraga C, Gallego-Fábrega C, Cárcel-Márquez J, Torres-Águila NP, et al. 2022. DNA methylation and ischemic stroke risk: an epigenome-wide association study. Thrombosis and haemostasis 122(10):1767−78

doi: 10.1055/s-0042-1749328
[50]

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, et al. 2018. Multiancestry genome-wide association study of 520, 000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics 50(4):524−37

doi: 10.1038/s41588-018-0058-3
[51]

Meng L, Wu B, OuYang L, Peng R, Chen Y, et al. 2024. Electroacupuncture regulates histone acetylation of Bcl-2 and Caspase-3 genes to improve ischemic stroke injury. Heliyon 10(6):e27045

doi: 10.1016/j.heliyon.2024.e27045
[52]

Deng GX, Xu N, Huang Q, Tan JY, Zhang Z, et al. 2019. Association between promoter DNA methylation and gene expression in the pathogenesis of ischemic stroke. Aging 11(18):7663

doi: 10.18632/aging.102278
[53]

Schwammenthal Y, Tanne D. 2004. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. The Lancet Neurology 3(8):493−95

doi: 10.1016/S1474-4422(04)00826-9